SEC 13F Intelligence

Deerfield Management Company, L.P. / EWTX

Deerfield Management Company, L.P.’s Edgewise Therapeutics Inc Position

Does Deerfield Management Company, L.P. own Edgewise Therapeutics Inc (EWTX)? Not currently — the last reported position was 765.7K shares worth $19M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$19M
Q4 2025
Shares
765.7K
% of Portfolio
+0.24%
Quarters Held
20
position exited

Position History EWTX

Reported value by quarter
Q1 ’21: $128MQ1 ’21Q2 ’21: $84MQ3 ’21: $65MQ4 ’21: $60MQ4 ’21Q1 ’22: $38MQ2 ’22: $31MQ3 ’22: $39MQ3 ’22Q4 ’22: $35MQ1 ’23: $26MQ2 ’23: $30MQ2 ’23Q3 ’23: $23MQ4 ’23: $43MQ1 ’24: $52MQ1 ’24Q2 ’24: $52MQ3 ’24: $48MQ4 ’24: $55MQ4 ’24Q1 ’25: $46MQ2 ’25: $27MQ3 ’25: $12MQ3 ’25Q4 ’25: $19Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025765.7K$19M+0.24%
Q3 2025765.7K$12M+0.19%
Q2 20252.07M$27M+0.49%
Q1 20252.08M$46M+0.90%
Q4 20242.08M$55M+1.05%
Q3 20241.78M$48M+0.71%
Q2 20242.87M$52M+0.86%
Q1 20242.87M$52M+0.91%
Q4 20233.93M$43M+0.79%
Q3 20233.93M$23M+0.50%
Q2 20233.93M$30M+0.65%
Q1 20233.93M$26M+0.58%
Q4 20223.93M$35M+0.73%
Q3 20223.93M$39M+0.77%
Q2 20223.93M$31M+0.65%
Q1 20223.93M$38M+0.85%
Q4 20213.93M$60M+1.26%
Q3 20213.93M$65M+1.27%
Q2 20213.93M$84M+1.49%
Q1 20213.93M$128M+2.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of EWTX.